Centre for Ophthalmology and Vision Science, University of Western Australia, Crawley, Western Australia 6009, Australia.
J Immunol. 2011 Feb 1;186(3):1713-22. doi: 10.4049/jimmunol.1003308. Epub 2010 Dec 27.
The Ly49H activating receptor on C57BL/6 (B6) NK cells plays a key role in early resistance to murine cytomegalovirus (MCMV) infection through specific recognition of the MCMV-encoded MHC class I-like molecule m157 expressed on infected cells. The m157 molecule is also recognized by the Ly49I inhibitory receptor from the 129/J mouse strain. The m157 gene is highly sequence variable among MCMV isolates, with many m157 variants unable to bind Ly49H(B6). In this study, we have sought to define if m157 variability leads to a wider spectrum of interactions with other Ly49 molecules and if this modifies host susceptibility to MCMV. We have identified novel m157-Ly49 receptor interactions, involving Ly49C inhibitory receptors from B6, BALB/c, and NZB mice, as well as the Ly49H(NZB) activation receptor. Using an MCMV recombinant virus in which m157(K181) was replaced with m157(G1F), which interacts with both Ly49H(B6) and Ly49C(B6), we show that the m157(G1F)-Ly49C interactions cause no apparent attenuating effect on viral clearance in B6 mice. Hence, when m157 can bind both inhibitory and activation NK cell receptors, the outcome is still activation. Thus, these data indicate that whereas m157 variants predominately interact with inhibitory Ly49 receptors, these interactions do not profoundly interfere with early NK cell responses.
B6 小鼠的 Ly49H 激活受体在识别受感染细胞上表达的 MCMV 编码的 MHC 类 I 样分子 m157 方面发挥关键作用,从而在早期抵抗小鼠巨细胞病毒(MCMV)感染。129/J 小鼠品系的 Ly49I 抑制受体也识别 m157 分子。MCMV 分离株之间的 m157 基因高度序列变异,许多 m157 变体无法与 Ly49H(B6)结合。在这项研究中,我们试图确定 m157 的变异性是否导致与其他 Ly49 分子的更广泛相互作用,如果这会改变宿主对 MCMV 的易感性。我们已经确定了新的 m157-Ly49 受体相互作用,涉及 B6、BALB/c 和 NZB 小鼠的 Ly49C 抑制受体,以及 Ly49H(NZB)激活受体。我们使用一种 MCMV 重组病毒,其中 m157(K181)被 m157(G1F)取代,该病毒与 Ly49H(B6)和 Ly49C(B6)都相互作用,我们表明 m157(G1F)-Ly49C 相互作用不会导致 B6 小鼠病毒清除的明显减弱效应。因此,当 m157 可以与抑制性和激活性 NK 细胞受体结合时,结果仍然是激活。因此,这些数据表明,尽管 m157 变体主要与抑制性 Ly49 受体相互作用,但这些相互作用不会严重干扰早期 NK 细胞反应。